Last reviewed · How we verify
NCT04798105
Predictors of Probabilistic Selection Task Performance
NA trial testing Effects of tDCS of dlPFC on Probabilistic Selection Task in Learning; Lack of (Specific) in 30 participants. Status unknown.
22 October 2021
Quick facts
| Lead sponsor | Charles Darwin University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 30 |
| Start date | 12 April 2021 |
| Primary completion | 22 October 2021 |
| Estimated completion | 22 October 2021 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Effects of tDCS of dlPFC on Probabilistic Selection Task
Conditions studied
- Learning; Lack of (Specific) — all drugs for Learning; Lack of (Specific) →
Sponsor
Charles Darwin University
Who can join
Adults 18 to 50, any sex, with Learning; Lack of (Specific). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project aims to investigate whether tDCS has an effect on reward and punishment learning sensitivity. Further, whether tDCS will modulate extraversion and impulsivity personality traits, and eye-blink-rate's effect on learning. For instance, trait extroversion in past research is linked to the dopamine neurotransmitter system, where it is thought that extreme low and high levels are detrimental to cognitive performance. Since tDCS has been shown to increase dopamine levels, it is thought that people who are already high in dopamine may experience less benefit (or even impairment) on cognitive performance following tDCS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04798105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Learning; Lack of (Specific)
Currently open trials in the same condition.
- NCT07185763 — Nano-Learning for Improving Compliance Among Older Adults With Sarcopenia · NA · active not recruiting
Other Charles Darwin University trials
Trials by the same sponsor.
- NCT06412107 — Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors · NA · completed
- NCT05257876 — Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors · NA · completed
- NCT04118140 — Somatic Acupressure for Symptom Cluster Management in Breast Cancer Patients · NA · completed
- NCT04190342 — Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients · NA · completed
- NCT05529238 — Kegel Exercises for Stress Urinary Incontinence · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04798105 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charles Darwin University
- Last refreshed: 28 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04798105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing